Clinical Implications of the 2004 WHO Histological Classification on Non-Invasive Tumours of the Urinary Bladder
Thomas Hofmann(Technical University of Munich), Dirk Zaak, Arndt Hartmann(Universitätsklinikum Erlangen), Christian G. Stief(LMU Klinikum), Alexander Karl(Ludwig-Maximilians-Universität München), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Derya Tilki(Koç University), Michael Seitz(Ludwig-Maximilians-Universität München), Ruth Knüchel‐Clarke(RWTH Aachen University)
Cited by 18
Related Papers
The Lancet Commission on prostate cancer: planning for the surge in cases
|The Lancet|2024|694
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411
Dose-Response Association of CD8<sup>+</sup> Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer
|JAMA Oncology|2017|409
Single-Step Percutaneous Nephrolithotomy (Microperc): The Initial Clinical Report
|The Journal of Urology|2011|276